BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11874083)

  • 1. Women with a pelvic mass: indicators of malignancy.
    Balbi GC; Musone R; Menditto A; Balbi F; Corcioni C; Calabria G; Maciariello C; Balbi C
    Eur J Gynaecol Oncol; 2001; 22(6):459-62. PubMed ID: 11874083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass.
    Mousavi AS; Borna S; Moeinoddini S
    Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer.
    Roman LD; Muderspach LI; Stein SM; Laifer-Narin S; Groshen S; Morrow CP
    Obstet Gynecol; 1997 Apr; 89(4):493-500. PubMed ID: 9083301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis?
    Valentin L; Ameye L; Jurkovic D; Metzger U; Lécuru F; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2006 Apr; 27(4):438-44. PubMed ID: 16526098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
    Fayed ST; Ahmad SM; Kassim SK; Khalifa A
    Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of pulsed color Doppler in the presurgical evaluation of pelvic masses].
    Salle B; Gaucherand P; Ecochard R; Rudigoz RC
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):234-40. PubMed ID: 7622769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.
    Mancuso A; De Vivo A; Triolo O; Irato S
    Eur J Gynaecol Oncol; 2004; 25(2):207-10. PubMed ID: 15032283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography.
    Franchi M; Beretta P; Ghezzi F; Zanaboni F; Goddi A; Salvatore S
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):734-9. PubMed ID: 7572110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.
    Schutter EM; Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2002 Aug; 187(2):385-92. PubMed ID: 12193930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.
    Timmerman D; Bourne TH; Tailor A; Collins WP; Verrelst H; Vandenberghe K; Vergote I
    Am J Obstet Gynecol; 1999 Jul; 181(1):57-65. PubMed ID: 10411796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Serum HE4, CA125, CA72-4, and ROMA Index for Diagnosis of Ovarian Cancer and Prediction of Postoperative Recurrence.
    Wang Q; Wu Y; Zhang H; Yang K; Tong Y; Chen L; Zhou Q; Guan S
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvaginal color Doppler and CA125 as tools in the differential diagnosis of postmenopausal ovarian masses.
    Botsis D; Kassanos D; Kalogirou D; Karakitsos P; Liapis A; Antoniou G
    Maturitas; 1997 Apr; 26(3):203-9. PubMed ID: 9147352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transvaginal sonography, color flow imaging, computed tomographic scanning, and CA 125 as a routine follow-up examination in women with pelvic tumor: detection of recurrent disease.
    Weiner Z; Beck D; Brandes JM
    J Ultrasound Med; 1994 Jan; 13(1):37-41. PubMed ID: 7636952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.